凯莱英 (002821.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

28.8x

Market Cap

CNY 56.47B

MomentumView details →

1D Return

−6.86%

YTD Return

+75.42%

RSI (14)

48.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

28.8x

Market Cap

CNY 56.47B

RSI (14)

48.0

MomentumView details →

1D Return

−6.86%

YTD Return

+75.42%

ProfitabilityView details →

Gross Margin

42.14%

Net Margin

16.02%

EBITDA Margin

26.17%

ROE (TTM)

6.18%

ROA (TTM)

5.36%

Asset Turnover

0.34x

GrowthView details →

Revenue YoY

+16.56%

EPS YoY

+10.22%

FCF YoY

−32.18%

Revenue CAGR 3Y

−13.36%

EPS CAGR 3Y

−29.50%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.30

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−8.51%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

5.69x

Quick Ratio

4.91x

Div Yield

0.80%

Div Rate

CNY 1.30

Div Growth 1Y

+18.18%

Financials snapshotView financials →

Revenue (TTM)

6.93B

Net Income (TTM)

1.11B

Op. CF (TTM)

1.48B

Next earningsNov 4, 2026 →

Latest newsMore news →

Asymchem Laboratories announced its first-half 2026 results: revenue of 3.607 billion yuan, up 13.13% year-on-year, and net profit attributable to shareholders of 520 million yuan, down 15.71% from 617 million yuan in the same period of 2025.11d ago

Chinese innovative drug and CXO stocks rebounded strongly, with the CSI Innovative Drug Industry Index rising 28.04% since June 9, 2026, and several stocks hitting daily limits on August 7, 2026.28d ago

Similar companies

兴森科技002436.SZ 华峰化学002064.SZ 晶盛机电300316.SZ 先导智能300450.SZ 迈为股份300751.SZ 华天科技002185.SZ Find similar companies →

Latest newsMore news →

Asymchem Laboratories announced its first-half 2026 results: revenue of 3.607 billion yuan, up 13.13% year-on-year, and net profit attributable to shareholders of 520 million yuan, down 15.71% from 617 million yuan in the same period of 2025.11d ago Chinese innovative drug and CXO stocks rebounded strongly, with the CSI Innovative Drug Industry Index rising 28.04% since June 9, 2026, and several stocks hitting daily limits on August 7, 2026.28d ago